About

Per gilead.com, Anthony Welters has served on Gilead's Board of Directors since 2020, and in May 2024 the independent directors unanimously appointed him Lead Independent Director in recognition of his leadership experience and in-depth knowledge of Gilead.

He has significant leadership experience on other public boards and extensive experience in the health insurance and managed care industry, with a demonstrated commitment to delivering healthcare to underserved communities.

Roles

Gilead Sciences, Inc.
Lead Independent Director · Current role
2020–present
UnitedHealth Group
Senior Adviser to the Office of the CEO

External Roles

CINQ Care
Chairman and Chief Executive Officer

Director Compensation

FY 2025
Fees earned or paid in cash
$180,041
Stock awards
$149,932
FormRSUs (1,516 shares granted May 7, 2025, vested immediately)
Option awards
$149,989
Total
$479,962

Also at Gilead Sciences, Inc.

Related

See how VectorShift works for your firm

Request Demo